United States · FDA National Drug Code directory
Fondaparinux Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0781-3454_3d5a4b69-462b-7e51-e063-6294a90a0721
- Product NDC
- 0781-3454
- Form
- INJECTION
- Composition / generic term
- Fondaparinux Sodium
- Labeler
- Sandoz Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190618
- Source listing expiry
- 20261231
Source-listed ingredients
- FONDAPARINUX SODIUM — 5 mg/.4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE in 1 CARTON (0781-3454-12) / .4 mL in 1 SYRINGE (0781-3454-94) · 0781-3454-12
- 10 SYRINGE in 1 CARTON (0781-3454-95) / .4 mL in 1 SYRINGE (0781-3454-94) · 0781-3454-95
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →